AFTINET: Reply to the Department of Foreign Affairs and Trade Myths and Realities document, June 2015

30-Jun-2015 Scoop The Australian government misrepresents the claims of critics and fails to address substantial criticisms of the Trans Pacific Partnership, says civil society network AFTINET.

  • 12-May-2011 FDA News
    PhRMA calls for strong IP protection for biologics in TPP FTA

    US pharmaceutical industry association the Pharmaceutical Research and Manufacturers of America is calling on the US Trade Representative to include strong intellectual property provisions, such as 12-year data protection for follow-on biologics, in the Trans-Pacific Partnership agreement.

  • 6-May-2011
    India, Mercosur "must withstand EU pharma demands"

    Nations currently negotiating trade deals with the European Union (EU) have been warned that they must resist European demands which could threaten access to medicines in emerging and developing countries.

  • 5-May-2011
    No compromise in our stance on IPR, says India

    India will not compromise its stand or take a position on intellectual property rights (IPR), especially on pharmaceuticals, beyond its domestic law and agreements as mandated under the aegis of the global trade body—World Trade Organization (WTO).

  • 1-May-2011 ANSA Latina
    Preocupación de laboratorios por TLC y trabas aduaneras

    BUENOS AIRES, 1 (ANSA) - Los laboratorios de capital nacional de América Latina debatirán a partir de mañana en El Salvador sobre las consecuencias de los tratados de libre comercio en la región y sobre la imposición de trabas aduaneras, que alientan la concentración monopólica de los mercados farmacéuticos.

  • 13-Apr-2011 ActUp Paris
    Guerre aux labos : La politique européenne tue

    Par le passé, les États-Unis ont signé avec des pays en développement des accords de libre-échange (ALE), aux effets désastreux sur les coûts des médicaments. Depuis quelques années, c’est au tour de l’Europe, sous l’impulsion de la France, du Royaume-Uni et de l’Allemagne, de prendre le relais de cette politique bilatérale, lourde de conséquences pour les malades.

  • 12-Apr-2011 FSRN
    India-EU FTA carries severe public health consequences

    After four years of talks, India and the European Union are narrowing down their differences on a bilateral Free Trade Agreement that critics in India and elsewhere say could have a devastating impact on public health by hampering access to life-saving drugs for millions of people.

  • 7-Apr-2011 MSF
    Europe opens new front against affordable medicines in trade deal with India

    As free trade agreement talks between Europe and India resume in Brussels today, the international medical humanitarian organisation Médecins Sans Frontières (MSF) is deeply concerned about new measures Europe is pushing to restrict the production of affordable generic medicines that MSF and others rely on to treat patients across the developing world.

  • 29-Mar-2011
    No data sharing on drugs of pharma cos in FTAs: Sharma

    India today ruled out sharing test data of drugs, or data exclusivity, of Indian pharma firms with developed countries and multi-national companies, and stressed that the provision will not form part of any free trade agreements pursued by the country.

  • 22-Mar-2011 Rue89
    Médicaments : l’Europe menace les génériques des pays pauvres

    L’accord, en négociation depuis trois ans, pourrait mettre un coup d’arrêt à la production de médicaments génériques en Inde.

  • 22-Mar-2011 KEI
    UN Special Raporteur on right to health asked to intervene in TPP Trade negotiation

    Eleven public interest advocacy groups and three law professors have submitted a petition to Anand Grover, the Special Rapporteur for the United Nations on the right to health, to intervene in a new regional trade agreement that will shrink the market for legal generic medecines.

  • 19-Mar-2011
    HAI Europe on EU-India & EU-Mercosur trade agreements

    All eyes are on the EU-India trade agreement, and the repercussions it will have on access to medicines in India and other developing countries. At the same time, the EU is in the process of negotiating other trade agreements that could harm or hinder access to medicines, such as this week’s negotiations between the EU and the Mercosur countries.

  • 15-Mar-2011
    Govt will protect interests of drug industry: Scindia

    Amid concerns expressed by the Indian industry, the government today said in Parliament that it will protect the interest of the domestic drug industry while finalising the free trade pact with European Union.

  • 15-Mar-2011
    India, EU settle generics dispute, pave way for FTA talks in April

    India has sorted out most of its differences with the European Union on production of low-cost generic medicines, ahead of a crucial meeting on a proposed free-trade pact next month, a government official told ET. Civil society groups, however, warn that India should be on its guard to ensure that the intellectual property rights (IPR) regime is not changed to allow extension of patents.

  • 8-Mar-2011 Act Up Paris
    Global e-protest against FTAs

    Write to members of Indian governement and European Commission to save affordable medicines and access to life-saving treatments in Africa, Asia and Latin America !

  • 4-Mar-2011
    Bodies express concern over potential negative impact of FTA

    Positive Living HIV (PLHIV) organisations in Malaysia yesterday expressed concern over the potential negative impact on HIV medication of Free Trade Agreements (FTAs) which the government is currently negotiating with the United States and the European Commission (EC).

  • 3-Mar-2011 IP Left
    Action against EU-India and EU-Korea FTA in Seoul

    The Korea-EU FTA must be dismantled. And the lives of patients in over 120 countries are on the line regarding the India-EU FTA. What will devastate the Pharmacy of the World must also be stopped.

  • 2-Mar-2011
    HIV patients say ‘no’ to IP provision on generic drugs

    People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.

  • 2-Mar-2011
    Thousands of people with HIV protest India-EU trade deal restricting access to cheap drugs

    Thousands of people with HIV and cancer marched through the streets of India’s capital Wednesday to protest a planned trade deal with the European Union that they claim would restrict access to affordable medicines.

  • 25-Feb-2011 Hindu Business Line
    EU’s pharma trade hoax

    The EU’s proposed trade agreement is riddled with intellectual property provisions that would harm India’s 2005 Patent Act and block public-interest rulings such as the Aluvia decision.

  • 23-Feb-2011 OS Blog
    The EU-India free trade agreement: An interview with Loon Gangte

    "It’s like an ant fighting an elephant. We are one of the weakest and poorest groups and they (the EU and the pharmaceutical industry) are among the richest and strongest."

  • 0 | ... | 80 | 100 | 120 | 140 | 160 | 180 | 200 | 220 | 240 | ... | 480